Cancers in the kidney with relatively better prognosis are mainly enriched in the TGF-β+ subtype, intestinal cancers are predominant in cell cycle and TP53 + subtype-specific, and head and neck cancers are enriched in TGF-β and TP53− subtype. This evidence concerns the gene TP53 and kidney cancer.